Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Medroxyprogesterone 200mg/5ml oral suspension
0803020H0AAAQAQ
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 20mg/5ml oral suspension
0803020H0AAAPAP
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 250mg tablets
0803020H0AAAEAE
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 400mg/5ml oral liquid
0803020H0AAAKAK
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg tablets
0803020H0AAAGAG
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Medroxyprogesterone 500mg/2.5ml inj vials
0803020H0AAABAB
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Megace 40mg tablets
0803020L0BBAAAA
|
Megace | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 10mg/5ml oral suspension
0803020L0AAAFAF
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 200mg/5ml oral suspension
0803020L0AAAGAG
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 20mg capsules
0803020L0AAAJAJ
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 20mg/5ml oral suspension
0803020L0AAAEAE
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 40mg/5ml oral suspension
0803020L0AAAHAH
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 50mg capsules
0803020L0AAAIAI
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 80mg tablets
0803020L0AAAKAK
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Megestrol 80mg/5ml oral suspension
0803020L0AAADAD
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | No data available |
|
Mekinist 0.5mg tablets
0801050CHBBAAAA
|
Mekinist | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Mekinist 2mg tablets
0801050CHBBABAB
|
Mekinist | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Mektovi 15mg tablets
0801050CNBBAAAA
|
Mektovi | Binimetinib | Malignant Disease and Immunosuppression | No data available |
|
Mektovi 45mg tablets
0801050CNBBABAB
|
Mektovi | Binimetinib | Malignant Disease and Immunosuppression | No data available |
|
Melphalan 50mg inj vials
0801010S0AAADAD
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Melphalan 5mg tablets
0801010S0AAACAC
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 12.5mg capsules
0801030L0AAASAS
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 20mg capsules
0801030L0AAARAR
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 25mg/5ml oral suspension
0801030L0AAAHAH
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
|
Mercaptopurine 30mg capsules
0801030L0AAAMAM
|
Mercaptopurine | Mercaptopurine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.